AngioDynamics, Inc. AngioDynamics, Inc.

AngioDynamics, Inc.

ANGO

Rank in Stocks #11984
AngioDynamics, Inc. specializes in the development, manufacturing, and... AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.
Share Price
$11.49
Last synced: 2026-11-17
Market Cap
$482.83M
Change (1 day)
-2.46%
Change (1 year)
-3.85%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
P/S ratio for AngioDynamics, Inc. (ANGO)
P/S ratio as of November 2026 TTM: 1.53
According to AngioDynamics, Inc.'s latest financial reports and stock price, its current price-to-sales ratio (TTM) is 1.53. At the end of 2025 the company had a P/S ratio of 1.43.
P/S ratio history for AngioDynamics, Inc. from 2001 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 1.53 7.29%
2025 1.43 71.31%
2024 0.83 -24.33%
2023 1.10 -54.47%
2022 2.42 -21.76%
2021 3.10 107.48%
2020 1.49 -23.87%
2019 1.96 -13.49%
2018 2.26 43.40%
2017 1.58 29.10%
2016 1.22 -24.04%
2015 1.61 13.37%
2014 1.42 28.26%
2013 1.11 -19.62%
2012 1.38 -23.79%
2011 1.81 10.81%
2010 1.63 5.43%
2009 1.55 -30.92%
2008 2.24 -13.99%
2007 2.60 -43.81%
2006 4.64 18.45%
2005 3.91 46.90%
2004 2.66 -10.97%
2003 2.99 -19.63%
2002 3.72 -24.28%
2001 4.92 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
13.28 765.66%
US
2.86 86.53%
FR
2.94 91.42%
US
7.93 417.14%
JP
3.26 112.31%
CH

Questions about AngioDynamics, Inc.'s P/S ratio

What is AngioDynamics, Inc.'s P/S ratio?

AngioDynamics, Inc.'s P/S ratio is 1.53, as of Nov 2026.

What was AngioDynamics, Inc.'s P/S ratio in 2025?

In 2025, AngioDynamics, Inc.'s P/S ratio was 1.43, compared with 0.83 in 2024.

How has AngioDynamics, Inc.'s P/S ratio changed since 2020?

From 2020 to 2025, AngioDynamics, Inc.'s P/S ratio was highest in 2021 (3.10) and lowest in 2024 (0.83).

How does AngioDynamics, Inc.'s P/S ratio compare with similar companies?

AngioDynamics, Inc.'s P/S ratio (1.53) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with 13.28.